급성 척수 손상 시장 규모는 향후 몇 년간 강력한 성장이 예상될 예정입니다. 예측 기간의 성장은 새로운 치료법, 원격 의료 도입, 환자 중심 치료 모델, 예방 의료 및 부상 예방에 대한 관심 증가에 기인할 수 있습니다. 예측 기간의 주요 동향은 의료 진보, 재활 기술, 신경 보호 요법, 심리 사회적 지원, 보도, 접근성 등이 있습니다.
교통사고 건수 증가가 향후 몇 년간 급성 척수 손상 시장의 성장을 견인할 것으로 예상됩니다. 사고로 인한 척수 손상은 중추 신경계(CNS)에 영향을 미치며 운동과 감각 기능에 필수적인 신경을 혼란시킬 수 있습니다. 외상을 일으켜 척수 손상이나 절단으로 이어질 수 있으며 마비를 일으킬 수 있습니다. Welsh Government가 보고한 2023년 교통사고 사상자 수는 4,348명으로 2022년부터 2% 증가했습니다.
임상시험 증가는 급성 척수 손상 시장의 확대를 촉진할 것으로 예상됩니다. 예를 들어, 2023년 5월 17일 기준 ClinicalTrials.gov에는 전 세계적으로 등록된 임상 연구가 452,604건이며, 64,838명이 참여자를 찾고 있었다고 보고되었습니다. 이는 2021년 초에 등록된 약 365,000건의 임상시험에서 크게 증가한 것을 의미합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 급성 척수 손상 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 급성 척수 손상 시장 : 성장률 분석
- 세계의 급성 척수 손상 시장 실적 : 규모와 성장(2019-2024년)
- 세계의 급성 척수 손상 시장 예측 : 규모와 성장(2024-2029년, 2034년)
- 세계의 급성 척수 손상 전체 시장(TAM)
제6장 시장 세분화
- 세계의 급성 척수 손상 시장 : 유형별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 완전 척수 손상
- 불완전 척수 손상
- 세계의 급성 척수 손상 시장 : 진단 유형별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 임상 검사
- 영상 검사
- 세계의 급성 척수 손상 시장 : 용도별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 병원
- 클리닉
- 세계의 급성 척수 손상 시장 : 완전 척수 손상 유형별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 사지 마비
- 하반신 마비
- 세계의 급성 척수 손상 시장 : 불완전 척수 손상 유형별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 중추 척수 증후군
- 전방 척수 증후군
- 브라운-세쿼드 증후군
- 코누스 메두라리스 증후군
- 카우다 에퀴나 증후군
제7장 지역별/국가별 분석
- 세계의 급성 척수 손상 시장 : 지역별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 급성 척수 손상 시장 : 국가별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 급성 척수 손상 시장 : 경쟁 구도
- 급성 척수 손상 시장 : 기업 프로파일
- Pfizer Inc 개요, 제품 및 서비스, 전략 및 재무 분석
- AbbVie Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Novartis AG 개요, 제품 및 서비스, 전략 및 재무 분석
- Teva Pharmaceutical Industries Ltd. 개요, 제품 및 서비스, 전략 및 재무 분석
- Biogen Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Vertex Pharmaceuticals Inc
- Mitsubishi Tanabe Pharma Corporation
- Stanford Health Care
- BioMarin Pharmaceutical Inc.
- Neuralstem Inc
- Kennedy Krieger Institute
- Acorda Therapeutics Inc
- Craig Hospital
- Omeros Corporation
- Lineage Cell Therapeutics Inc
- Pharmazz Inc.
- Asterias Biotherapeutics Inc
- Histocell SL
- Athersys Inc.
- ReNetX Bio
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 급성 척수 손상 시장(2029년) : 새로운 기회를 제공하는 국가
- 급성 척수 손상 시장(2029년) : 새로운 기회를 제공하는 부문
- 급성 척수 손상 시장(2029년) : 성장 전략
제36장 부록
KTH
An acute spinal cord injury (SCI) is a traumatic condition characterized by the potential occurrence of a spinal cord contusion (bruising), partial tearing, or complete transection (full severance) resulting from a traumatic event. Such injuries can lead to a significant reduction or complete loss of mobility, sensory perception, and organ function below the point of injury. Acute spinal cord injuries tend to be more prevalent among males and young adults, with causes ranging from motor vehicle accidents, falls, sports-related incidents, to complications arising from surgical procedures.
The primary categories of acute spinal cord injuries are complete and incomplete injuries. A complete spinal cord injury signifies the total absence of sensory and motor capabilities below the level of the injury. Medical professionals typically employ laboratory tests and various imaging procedures within hospital and clinical settings to diagnose these injuries.
The acute spinal cord injury market research report is one of a series of new reports from The Business Research Company that provides acute spinal cord injury market statistics, including acute spinal cord injury industry global market size, regional shares, competitors with a acute spinal cord injury market share, detailed acute spinal cord injury market segments, market trends and opportunities and any further data you may need to thrive in the acute spinal cord injury industry. This acute spinal cord injury market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The acute spinal cord injury market size has grown strongly in recent years. It will grow from $6.7 billion in 2024 to $7.08 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to rising incidence of acute spinal cord injuries, increasing awareness of acute spinal cord injury's and their treatment options, growing demand for personalized care, rising disposable income levels, increasing government spending on asci research and development.
The acute spinal cord injury market size is expected to see strong growth in the next few years. It will grow to $8.77 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to emerging therapies, telemedicine adoption, patient-centric care models, increasing focus on preventive healthcare and injury prevention. Major trends in the forecast period include medical advancements, rehabilitation techniques, neuroprotection therapies, psychosocial support, advocacy and accessibility.
The growing number of road accidents is expected to drive the growth of the acute spinal cord injury market in the coming years. A road accident involves the collision of a motor vehicle, leading to injury or potentially fatal consequences. Spinal cord injuries resulting from accidents can affect the central nervous system (CNS), disrupting the nerves essential for movement and sensory functions. The force of the impact during an accident can cause trauma to the cervical, lumbar, or thoracic spine, leading to damage or severing of the spinal cord, which may result in paralysis. For example, in June 2024, according to the Welsh Government, a government body in Wales, police reported a total of 4,348 road casualties in 2023, marking a 2% increase from 2022. Therefore, the rise in road accidents is contributing to the growth of the acute spinal cord injury market.
The growing number of clinical trials is expected to drive the expansion of the acute spinal cord injury market. Clinical trials play a vital role in advancing our knowledge and treatment options for Acute Spinal Cord Injury (SCI). These trials systematically investigate new therapies, treatments, or interventions to evaluate their safety and effectiveness in SCI patients. For example, as of May 17, 2023, ClinicalTrials.gov reported 452,604 globally registered clinical studies, with 64,838 actively seeking participants. This represents a significant increase from the approximately 365,000 registered trials in early 2021. Hence, the increasing number of clinical trials is a key factor fueling the growth of the acute spinal cord injury market.
Prominent companies operating in this space are dedicated to creating innovative medications to better serve their patients and maintain their market positions. The development of novel drugs, such as LYVISPAH, has the potential to improve treatment outcomes, particularly through combination therapy. For instance, in July 2022, Amneal Pharmaceuticals, a US-based pharmaceutical firm, introduced LYVISPAH, an FDA-approved baclofen oral granule available in 5 mg, 10 mg, and 20 mg doses. LYVISPAH is designed to treat spasticity associated with multiple sclerosis and other spinal cord disorders, addressing issues like flexor spasms, related pain, muscle rigidity, and spasticity. It offers flexible dosing options and is bioequivalent to oral baclofen tablets, potentially benefiting patients with spinal cord injuries and related conditions.
In February 2023, Globus Medical Inc., a US-based company specializing in musculoskeletal device solutions, completed the acquisition of NuVasive Inc. for $3.1 billion. This strategic move empowered Globus Medical to strengthen and expand its portfolio in musculoskeletal disorder devices, positioning it as a leading company in musculoskeletal technology. NuVasive Inc. is a US-based firm known for its development of medical devices and procedures for minimally invasive spinal cord surgery.
Major companies operating in the acute spinal cord injury market are Pfizer Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Biogen Inc., Vertex Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation, Stanford Health Care, BioMarin Pharmaceutical Inc., Neuralstem Inc., Kennedy Krieger Institute, Acorda Therapeutics Inc., Craig Hospital, Omeros Corporation, Lineage Cell Therapeutics Inc., Pharmazz Inc., Asterias Biotherapeutics Inc., Histocell S.L., Athersys Inc., ReNetX Bio, Kringle Pharma Inc., BioArctic AB, BioAxone BioSciences Inc., InVivo Therapeutics Holdings Corp, Geron Corporation, Neuronax SA, Tenax Therapeutics, Eusol Biotech Co. Ltd.
North America was the largest region in the acute spinal cord injury market in 2024. The regions covered in acute spinal cord injury report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the acute spinal cord injury market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The acute spinal cord injury market include revenues earned through entities by types such as complete spinal cord injury and incomplete spinal cord injury. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Acute Spinal Cord Injury Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on acute spinal cord injury market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for acute spinal cord injury ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acute spinal cord injury market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Complete Spinal Cord Injury; Incomplete Spinal Cord Injury
- 2) By Diagnosis Type: Laboratory Tests; Imaging Tests
- 3) By Application: Hospitals; Clinics
- Subsegments:
- 1) By Complete Spinal Cord Injury: Tetraplegia; Paraplegia
- 2) By Incomplete Spinal Cord Injury: Central Cord Syndrome; Anterior Cord Syndrome; Brown-Sequard Syndrome; Conus Medullaris Syndrome; Cauda Equina Syndrome
- Companies Mentioned: Pfizer Inc; AbbVie Inc.; Novartis AG; Teva Pharmaceutical Industries Ltd.; Biogen Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Acute Spinal Cord Injury Market Characteristics
3. Acute Spinal Cord Injury Market Trends And Strategies
4. Acute Spinal Cord Injury Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Acute Spinal Cord Injury Growth Analysis And Strategic Analysis Framework
- 5.1. Global Acute Spinal Cord Injury PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Acute Spinal Cord Injury Market Growth Rate Analysis
- 5.4. Global Acute Spinal Cord Injury Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Acute Spinal Cord Injury Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Acute Spinal Cord Injury Total Addressable Market (TAM)
6. Acute Spinal Cord Injury Market Segmentation
- 6.1. Global Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Complete Spinal Cord Injury
- Incomplete Spinal Cord Injury
- 6.2. Global Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Laboratory Tests
- Imaging Tests
- 6.3. Global Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Clinics
- 6.4. Global Acute Spinal Cord Injury Market, Sub-Segmentation Of Complete Spinal Cord Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tetraplegia
- Paraplegia
- 6.5. Global Acute Spinal Cord Injury Market, Sub-Segmentation Of Incomplete Spinal Cord Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Central Cord Syndrome
- Anterior Cord Syndrome
- Brown-Sequard Syndrome
- Conus Medullaris Syndrome
- Cauda Equina Syndrome
7. Acute Spinal Cord Injury Market Regional And Country Analysis
- 7.1. Global Acute Spinal Cord Injury Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Acute Spinal Cord Injury Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Acute Spinal Cord Injury Market
- 8.1. Asia-Pacific Acute Spinal Cord Injury Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Acute Spinal Cord Injury Market
- 9.1. China Acute Spinal Cord Injury Market Overview
- 9.2. China Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Acute Spinal Cord Injury Market
- 10.1. India Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Acute Spinal Cord Injury Market
- 11.1. Japan Acute Spinal Cord Injury Market Overview
- 11.2. Japan Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Acute Spinal Cord Injury Market
- 12.1. Australia Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Acute Spinal Cord Injury Market
- 13.1. Indonesia Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Acute Spinal Cord Injury Market
- 14.1. South Korea Acute Spinal Cord Injury Market Overview
- 14.2. South Korea Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Acute Spinal Cord Injury Market
- 15.1. Western Europe Acute Spinal Cord Injury Market Overview
- 15.2. Western Europe Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Acute Spinal Cord Injury Market
- 16.1. UK Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Acute Spinal Cord Injury Market
- 17.1. Germany Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Acute Spinal Cord Injury Market
- 18.1. France Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Acute Spinal Cord Injury Market
- 19.1. Italy Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Acute Spinal Cord Injury Market
- 20.1. Spain Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Acute Spinal Cord Injury Market
- 21.1. Eastern Europe Acute Spinal Cord Injury Market Overview
- 21.2. Eastern Europe Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Acute Spinal Cord Injury Market
- 22.1. Russia Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Acute Spinal Cord Injury Market
- 23.1. North America Acute Spinal Cord Injury Market Overview
- 23.2. North America Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Acute Spinal Cord Injury Market
- 24.1. USA Acute Spinal Cord Injury Market Overview
- 24.2. USA Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Acute Spinal Cord Injury Market
- 25.1. Canada Acute Spinal Cord Injury Market Overview
- 25.2. Canada Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Acute Spinal Cord Injury Market
- 26.1. South America Acute Spinal Cord Injury Market Overview
- 26.2. South America Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Acute Spinal Cord Injury Market
- 27.1. Brazil Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Acute Spinal Cord Injury Market
- 28.1. Middle East Acute Spinal Cord Injury Market Overview
- 28.2. Middle East Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Acute Spinal Cord Injury Market
- 29.1. Africa Acute Spinal Cord Injury Market Overview
- 29.2. Africa Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Acute Spinal Cord Injury Market Competitive Landscape And Company Profiles
- 30.1. Acute Spinal Cord Injury Market Competitive Landscape
- 30.2. Acute Spinal Cord Injury Market Company Profiles
- 30.2.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Acute Spinal Cord Injury Market Other Major And Innovative Companies
- 31.1. Vertex Pharmaceuticals Inc
- 31.2. Mitsubishi Tanabe Pharma Corporation
- 31.3. Stanford Health Care
- 31.4. BioMarin Pharmaceutical Inc.
- 31.5. Neuralstem Inc
- 31.6. Kennedy Krieger Institute
- 31.7. Acorda Therapeutics Inc
- 31.8. Craig Hospital
- 31.9. Omeros Corporation
- 31.10. Lineage Cell Therapeutics Inc
- 31.11. Pharmazz Inc.
- 31.12. Asterias Biotherapeutics Inc
- 31.13. Histocell S.L.
- 31.14. Athersys Inc.
- 31.15. ReNetX Bio
32. Global Acute Spinal Cord Injury Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Acute Spinal Cord Injury Market
34. Recent Developments In The Acute Spinal Cord Injury Market
35. Acute Spinal Cord Injury Market High Potential Countries, Segments and Strategies
- 35.1 Acute Spinal Cord Injury Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Acute Spinal Cord Injury Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Acute Spinal Cord Injury Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
